PLXPライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (13 4月 2023 @ 05:00):

Stats
本日の出来高	50.38M
平均出来高	4.86M
時価総額	2.53M
EPS	$0 ( 2023-11-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.223
ATR14	$0.0270 (469.57%)

Insider Trading

Date	Person	Action	Amount	type
2022-03-15	Giordano Natasha	Buy	4 100	Common Stock
2022-03-15	O'connor Rita M	Buy	3 700	Common Stock
2022-03-15	O'connor Rita M	Buy	10 000	Common Stock
2022-02-22	Valentino Michael J	Buy	80 000	Stock Option (right to buy)
2022-02-22	O'connor Rita M	Buy	110 000	Stock Option (right to buy)

INSIDER POWER
0.00
Last 94 transactions
Buy: 5 718 001 \| Sell: 1 856 163

ボリューム相関

長: 0.18 (neutral)

短: -0.79 (moderate negative)

Signal:(38.252) Neutral

PLx Pharma Inc 相関

10 最も正の相関
ONCS	0.955
WISA	0.952
INSG	0.947
IMRX	0.943
PRTK	0.943
INVE	0.943
TOI	0.942
VERV	0.938
TIL	0.937
TFFP	0.935

10 最も負の相関
AGFS	-0.912
CCRC	-0.91
LRFC	-0.907
MNKD	-0.903
IBEX	-0.901
STAY	-0.896
LWAC	-0.894
NWFL	-0.892
HZNP	-0.889
SLGN	-0.887

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

PLx Pharma Inc 相関 - 通貨/商品

-0.76
( moderate negative )

-0.71
( moderate negative )

0.00
( neutral )

-0.65
( weak negative )

-0.30
( neutral )

0.40
( neutral )

PLx Pharma Inc 財務諸表

Annual	2021
収益:	$8.21M
総利益:	$3.40M (41.46 %)
EPS:	$-1.714

FY	2021
収益:	$8.21M
総利益:	$3.40M (41.46 %)
EPS:	$-1.714

FY	2020
収益:	$30 430.00
総利益:	$30.43 (0.10 %)
EPS:	$-1.740

FY	2019
収益:	$565 464
総利益:	$0.00 (0.00 %)
EPS:	$-2.30

Financial Reports:

No articles found.

PLx Pharma Inc

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.